Photo taken from Jen Lovick/X
Jun 7, 2024, 02:12
Jen Lovick: It was great following ASCO24 on social media
Jen Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, shared a post by OncoDaily, on X:
“While ASCO24 is at an end, it was great following all of it on social media. If you were at ASCO and interested in potential collaborations with the journal Technology in Cancer Research and Treatment, please feel free to reach out.
Thanks for sharing OncoDaily!”
Quoting OncoDaily‘s post:
“I’m not at ASCO but still interested in connecting to discuss potential collaborations with the journal TCRT – Jen Lovick.”
Read further.
Source: Jen Lovick/X and OncoDaily/X